Pablo Iribarren Selected Research

Immunotherapy

1/2014

Abrogation of TNFα production during cancer immunotherapy is crucial for suppressing side effects due to the systemic expression of IL-12.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pablo Iribarren Research Topics

Disease

11	Alzheimer Disease (Alzheimer's Disease) 07/2007 - 11/2003
8	Inflammation (Inflammations) 01/2019 - 01/2002
7	Neoplasms (Cancer) 01/2014 - 01/2002
4	Infections 01/2023 - 01/2002
3	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018 - 02/2004
3	Glioma (Gliomas) 04/2006 - 10/2004
2	Neuroinflammatory Diseases 04/2022 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 01/2019
2	Central Nervous System Diseases (CNS Diseases) 02/2007 - 07/2004
2	Glioblastoma (Glioblastoma Multiforme) 04/2006 - 06/2005
2	Leukemia 10/2004 - 07/2004
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	COVID-19 01/2023
1	Splenomegaly 04/2022
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Encephalitis (Encephalitis, Rasmussen) 09/2011
1	Bacterial Infections (Bacterial Infection) 02/2006
1	Infertility (Sterility) 09/2004
1	Virus Diseases (Viral Diseases) 01/2003

Drug/Important Bio-Agent (IBA)

10	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 07/2007 - 11/2003
9	Peptides (Polypeptides)IBA 07/2007 - 11/2003
8	Amyloid beta-PeptidesIBA 07/2007 - 11/2003
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2004
5	CytokinesIBA 01/2023 - 02/2007
5	Chemotactic FactorsIBA 02/2006 - 01/2002
4	GTP-Binding Proteins (G-Protein)IBA 02/2006 - 02/2004
3	ChemokinesIBA 01/2023 - 04/2004
3	Interleukin-12 (IL 12)IBA 04/2022 - 07/2009
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2006 - 04/2004
2	Small Interfering RNA (siRNA)IBA 06/2005 - 10/2004
2	LigandsIBA 02/2004 - 02/2004
1	C-Reactive ProteinIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Interleukin-18 (Interleukin 18)IBA 04/2022
1	fludarabineIBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	SynucleinsIBA 01/2019
1	Peptidoglycan (Murein)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Interleukin-4 (Interleukin 4)IBA 09/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2007
1	CD40 Ligand (CD40L)IBA 02/2007
1	Lipoxygenase InhibitorsIBA 04/2006
1	N-Formylmethionine Leucyl-PhenylalanineIBA 04/2006
1	nordyIBA 04/2006
1	Masoprocol (Actinex)FDA Link 04/2006
1	VimentinIBA 04/2006
1	Toll-Like Receptor 2IBA 02/2006
1	AcidsIBA 02/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2005
1	Amyloid (Amyloid Fibrils)IBA 11/2005
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2005
1	A-factor (Streptomyces)IBA 06/2005
1	Amino Acids FDA Link 02/2005
1	MMK-1 peptideIBA 02/2005
1	Progesterone FDA LinkGeneric 09/2004
1	CalciumIBA 09/2004
1	peptide AIBA 07/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2004
1	Cyclic ADP-Ribose (cADPR)IBA 02/2004
1	Superoxides (Superoxide)IBA 02/2004
1	Chemokine ReceptorsIBA 01/2003

Therapy/Procedure

1	Immunomodulation 04/2022
1	Immunotherapy 01/2014